Zavzpret (zavegepant) has potential interactions with some other medications. For example, Zavzpret can interact with decongestant nasal sprays. Zavzpret is used in adults to treat migraine ...

Zavzpret is a small-molecule drug that targets the CGRP receptor. It’s an acute nasal spray you use as needed for migraine attacks with or without aura. It is the first medication that acts on ...

Pfizer has a second FDA approval for a migraine therapy stemming from its $11.6 billion Biohaven takeover, getting the go-ahead for intranasal therapy Zavzpret to sit alongside its fast-growing ...

A fourth gepant, this one in the form of a nasal spray called zavegepant (Zavzpret), was approved in March 2023 as an acute treatment for migraine. In August 2023, the European Commission ...